covid testing kit maker quidel's stock over the last year, it has done incredibly well.the last week it's up 4.7% but the company, this is breaking news, it has just been granted its second emergency use authorization from the fda of two tests that it makes, in just the span of one week. in fact, the most recent one came just a couple of hours ago. this is a company which the big ten and pac-12 chose to use to test their football players and keep their football season open. thanks to quidel both leagues completely finished their season and crowned new champions. here in a fox business exclusive, we are joined by the president and ceo, doug bryant. doug, first to the breaking news. within the last few hours, the fda just granted your test emergency use authorization. what was that moment like for you and the company? >> great. thanks, liz. thanks for having me. thanks for the question. let me just start first by saying before i respond that we are so incredibly proud of the organization, the team here at quidel for having risen to the challenge of the pandemic, throughout

healthcare. 2020 is all about covid so the covid stocks have done well, moderna with the vaccine, quidelfallen out of love with the countries that'd researcher epidemics that are going to be here long after covid, cancer, diabetes, ortho pete ices for the aging population, so you look at companies like exact sciences, tandem diabetes, stryk er on the orthopaedic side those are the kind of companies that are going to do very well next year so i think that is the real reopening trade that not enough people are talking about right now. ashley: tell us about your stocking stuffer stock, and i've been practicing that all morning stocking stuffer stock. >> it's a tongue twister. ashley: what's your pick? >> so the stocking stuffer it's a true stocking stuffer. this thing isn't even big enough to wrap and put under the tree. $400 million company, right? small company but exciting. the name of the company is dermt ek dmtk, so they're doing the exact same thing that exact sciences did for colon cancer for melanoma so they are rolling out a patient-friendly, less-invasive, more accurate way to tes